Impact of intracellular β-amyloid in transgenic animals and cell models

Neurodegenerative Diseases

Volumn 5, Issue 3-4, 2008, Pages 146-148

  Cuello, A Claudio ^a   Canneva, Fabio ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cell signaling; Cyclic AMP response element regulated gene expression; Intracellular amyloid; Synaptic plasticity; Transgenic models

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; CONFERENCE PAPER; CYCLIC AMP RESPONSIVE ELEMENT; DISEASE MODEL; DOWN SYNDROME; GENE EXPRESSION REGULATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELLS, CULTURED; HUMANS; INTRACELLULAR FLUID; NEURONS;

EID: 40449092370     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000113686     Document Type: Conference Paper

References (34)

1. Spillantini MG, Goedert M, Jakes R, Klug A: Different configurational states of beta-amyloid and their distributions relative to plaques and tangles in Alzheimer disease. Proc Natl Acad Sci USA 1990;87:3947-3951.
2. Bayer TA, Wirths O, Majtenyi K, Hartmann T, Multhaup G, Beyreuther K, et al: Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol 2001;11:1-11.
3. 42 accumulation in human brain. Am J Pathol 2000;156:15-20.
4. 42 accumulation in Down syndrome brain. Amyloid 2002;9:88-102.
5. Echeverria V, Cuello AC: Intracellular Abeta amyloid, a sign for worse things to come? Mol Neurobiol 2002;26:299-316.
6. Gouras GK, Almeida CG, Takahashi RH: Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 2005;26:1235-1244.
7. LaFerla FM, Green KN, Oddo S: Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 2007;8:499-509.
8. Wilson CA, Doms RW, Lee VM: Intracellular APP processing and A beta production in Alzheimer disease. J Neuropathol Exp Neurol 1999;58:787-794.
9. Wertkin AM, Turner RS, Pleasure SJ, Golde TE, Younkin SG, Trojanowski JQ, et al: Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proc Natl Acad Sci USA 1993;90:9513-9517.
10. Cook DG, Forman MS, Sung JC, Leight S, Kolson DL, Iwatsubo T, et al: Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med 1997;3:1021-1023.
11. 40/42 amyloid peptides. Nat Med 1997;3:1016-1020.
12. Bu G, Cam J, Zerbinatti C: LRP in amyloid-beta production and metabolism. Ann NY Acad Sci 2006;1086:35-53.
13. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY: Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 2002;110:199-211.
14. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, Reitz AB: Beta-amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 2000;275:5626-5632.
15. Knauer MF, Soreghan B, Burdick D, Kosmoski J, Glabe CG: Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc Natl Acad Sci USA 1992;89:7437-7441.
16. 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J Biol Chem 1995;270:14786-14792.
17. 1-42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 2002;161:1869-1879.
18. Almeida CG, Takahashi RH, Gouras GK: Beta-amyloid accumulation impairs multi-vesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci 2006;26:4277-4288.
19. Oh S, Hong HS, Hwang E, Sim HJ, Lee W, Shin SJ, et al: Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech Ageing Dev 2005;126:1292-1299.
20. Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM: Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging 2007, E-pub ahead of print.
21. Grant SM, Shankar SL, Chalmers-Redman RM, Tatton WG, Szyf M, Cuello AC: Mitochondrial abnormalities in neuroectodermal cells stably expressing human amyloid precursor protein (hAPP751). Neuroreport 1999;10:41-46.
22. Busciglio J, Pelsman A, Wong C, Pigino G, Yuan M, Mori H, et al: Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 2002;33:677-688.
23. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, et al: Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 2005;19:2040-2041.
24. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al: ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004;304:448-452.
25. Echeverria V, Ducatenzeiler A, Alhonen l, Janne J, Grant SM, Wandosell F, et al: Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex. J Alzheimers Dis 2004;6:209-219.
26. Lopez EM, Bell KF, Ribeiro-da-Silva A, Cuello AC: Early changes in neurons of the hippocampus and neocortex in transgenic rats expressing intracellular human A-beta. J Alzheimers Dis 2004;6:421-431.
27. Nixon RA, Cataldo AM, Mathews PM: The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochem Res 2000;25:1161-1172.
28. Vercauteren FG, Clerens S, Roy L, Hamel N, Arckens L, Vandesande F, et al: Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1. Brain Res Mol Brain Res 2004;132:241-259.
29. Grant SM, Morinville A, Maysinger D, Szyf M, Cuello AC: Phosphorylation of mitogenactivated protein kinase is altered in neuroectodermal cells overexpressing the human amyloid precursor protein 751 isoform. Brain Res Mol Brain Res 1999;72:115-120.
30. Echeverria V, Ducatenzeiler A, Dowd E, Janne J, Grant SM, Szyf M, et al: Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience 2004;129:583-592.
31. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003;39:409-421.
32. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM: Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005;45:675-688.
33. Echeverria V, Ducatenzeiler A, Chen CH, Cuello AC: Endogenous beta-amyloid peptide synthesis modulates cAMP response element-regulated gene expression in PC12 cells. Neuroscience 2005;135:1193-1202.
34. Arvanitis DN, Ducatenzeiler A, Ou JN, Grodstein E, Andrews SD, Tendulkar SR, et al: High intracellular concentrations of amyloid-beta block nuclear translocation of phosphorylated CREB. J Neurochem 2007;103:216-228.